×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 1: Risk Based Monitoring: Evolving Industry Perspectives
Session Chair(s)
Chirag Trivedi
Director, Clinical Study Unit,
Sanofi India Limited, India
Speaker(s)
TransCelerate BioPharma: IQRMP, RACT and QBD
Chirag Trivedi
Sanofi India Limited, India
Director, Clinical Study Unit,
TransCelerate BioPharma: IQRMP, RACT and QBD
Subashri Shivkumar
IQVIA, India
Senior Director & Head Clinical Development Services, India & SriLanka,
Sumit Goyal
Syneos Health, United States
Director, Clinical Research
Have an account?